基于Joinpoint回归模型分析2005—2021我国甲型肝炎发病趋势

doi:10.12183/j.scjpm.2024.0604

华南预防医学 ›› 2024, Vol. 50 ›› Issue (7): 604-607.doi: 10.12183/j.scjpm.2024.0604

基于Joinpoint回归模型分析2005—2021我国甲型肝炎发病趋势

张家玮², 周敏¹, 苏永健^1,2,3, 赵文文^1,2, 戴诗燕^1,2, 李海^1,2

1.广西中医药大学公共卫生与管理学院,广西南宁 530200;
2.广西中医药大学广西高发传染病中西医结合转化医学重点实验室;
3.广西中医药大学附属瑞康医院

收稿日期:2023-11-21 出版日期:2024-07-20 发布日期:2024-08-12
通讯作者: 李海,E-mail：34257040@qq.com
作者简介:张家玮（1997—）,女,硕士研究生,研究方向：传染病的预防和控制;周敏（2000―）,女,大学本科,研究方向：传染病的预防和控制。张家玮和周敏为共同第一作者
基金资助:
2021年广西自然科学基金项目面上项目（2021GXNSFAA220110）; 广西中医药大学—深圳康泰生物制品股份有限公司广西预防控制乙肝项目（QT022019）; 广西中医药大学2021年研究生教育创新计划项目校级课题（YCXJ2021030）; 广西中医药大学高层次公共卫生人才培育创新团队资助项目（2022A009）; 广西中医药大学桂派杏林拔尖人才项目（2022C010）

Incidence trend of hepatitis A in China from 2005 to 2021：an analysis based on Joinpoint regression model

ZHANG Jiawei^1,2, ZHOU Min¹, SU Yongjian^1,2,3, ZHAO Wenwen^1,2, DAI Shiyan^1,2, LI Hai^1,2

1. School of Public Health and Management,Guangxi University of Chinese Medicine,Nanning 530200,China;
2. Guangxi Key Laboratory of Translational Medicine for Treating High-incidence Infectious Diseases with Integrative Medicine,Guangxi University of Chinese Medicine;
3. Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine

Received:2023-11-21 Online:2024-07-20 Published:2024-08-12

摘要/Abstract

摘要： 目的分析2005—2021年我国甲型肝炎（甲肝）报告发病率的变化趋势,为甲肝的防治工作提供参考。方法从中国疾病预防控制中心的公共卫生科学数据中心和国家卫生健康委员会疾病预防控制局的工作动态以及国家统计局的人口资料中分别获取疾病数据和人口数据。采用Joinpoint回归模型分析我国甲肝报告发病趋势。结果 2005—2021年我国共报告582 531例甲肝病例,年平均报告发病率为2.534 3/10万,平均年度变化百分比（AAPC）为-10.00%（P<0.001）,呈下降趋势。2005—2018年我国有26个省级行政区甲肝报告发病率呈下降趋势（P<0.05或P<0.01）,5个省级行政区报告发病率呈平稳趋势（均P>0.05）;除1~<2岁组和≥85岁组变化趋势无统计学意义（均P>0.05）外,其他年龄组为下降趋势（均P<0.01）。结论 2005—2021年我国甲肝总体报告发病率处于下降趋势,但仍需落实健康教育,强化人群疾病预防意识和自我保护能力。

关键词: 甲型肝炎, 发病趋势, Joinpoint回归模型

Abstract: Objective To analyze the incidence trend of hepatitis A in China from 2005 to 2021,and provide the scientific reference for the prevention and treatment of hepatitis A. Methods Disease data and population data were obtained from the Public Health Science Data Center of the Chinese Center for Disease Control and Prevention and the work dynamics of the Bureau of Disease Control and Prevention of the National Health Commission,as well as the population data of the National Bureau of Statistics. Joinpoint regression model was used to analyze the reported incidence trend of hepatitis A in China. Results A total of 582 531 cases of hepatitis A were reported in China from 2005 to 2021,with an average annual reported incidence of 2.5343/100 000 and an average annual percent change （AAPC） of -10.00% （P<0.001）,showing a downward trend. From 2005 to 2018,the reported incidence of hepatitis A showed a decreasing trend in 26 provincial administrative regions （P<0.05 or P<0.01）,and a stable trend in 5 provincial administrative regions （all P>0.05）. There was no statistical significance in the 1-year-old group and the ≥85 year-old group （both P>0.05）,and the other age groups showed a downward trend （all P<0.01）. Conclusion The overall reported incidence of hepatitis A in China from 2005 to 2021 is in a downward trend,but it is still necessary to implement health education and strengthen the disease prevention awareness and self-protection ability of the population.

Key words: Hepatitis A, Incidence trend, Joinpoint regression model

中图分类号:

R183.4

张家玮, 周敏, 苏永健, 赵文文, 戴诗燕, 李海. 基于Joinpoint回归模型分析2005—2021我国甲型肝炎发病趋势[J]. 华南预防医学, 2024, 50(7): 604-607.

ZHANG Jiawei, ZHOU Min, SU Yongjian, ZHAO Wenwen, DAI Shiyan, LI Hai. Incidence trend of hepatitis A in China from 2005 to 2021：an analysis based on Joinpoint regression model[J]. South China Journal of Preventive Medicine, 2024, 50(7): 604-607.

参考文献

[1] Cao G,Jing W,Liu J,et al.The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention[J].hepatol Int,2021,15(5):1-15.
[2] Sun J,Li Y,Fang X,et al.An epidemic of hepatitis A-Liaoning Province,2020[J]. China CDC weekly,2020,2(30):570-574.
[3] 聂艳武,马玉花,王琛琛,等.基于Joinpoint和APC模型的2010—2019年新疆克拉玛依市队列人群HPV感染特征及趋势分析[J].现代预防医学,2022,49(11):1921-1925.
[4] Zheng B,Wen Z,Pan J,et al.Epidemiologic trends of hepatitis A in different age groups and regions of China from 1990 to 2018:Observational population-based study[J].Epidemiol Infect,2021,149(186):e186.
[5] 唐林,刘倩倩,王晓琪,等.中国扩大国家免疫规划前后不同流行区甲型肝炎报告发病率变化的中断时间序列分析[J].中国疫苗和免疫,2022,28(1):19-25.
[6] 李丽红,邓琳菲,王承训,等.长春地区儿童甲型肝炎自然感染率的调查[J].中国优生与遗传杂志,2007,15(1):106-107.
[7] 马超,安志杰,曾玫,等.《国家免疫规划疫苗儿童免疫程序及说明(2021年版)》要点解析[J].中国疫苗和免疫,2021,27(3):235-241.
[8] 蒙洋,蒋红云.甲型肝炎疫苗研究进展[J].江西化工,2020(4):94-95.
[9] 张超,罗小福,徐秦儿.应用中断时间序列评价甲肝疫苗纳入扩大免疫规划对甲肝发病的影响[J].预防医学,2019,31(6):553-557.
[10] 孙校金,王富珍,郑徽,等.2004—2015年中国甲型病毒性肝炎流行病学特征分析[J].中华预防医学杂志,2017,51(12):1091-1096.
[11] 胡晓彤. 我国不同流行程度地区甲肝病原学监测及传播学特征研究[D].杭州:浙江大学,2021.
[12] Ming BW,Yang Z,Yan ZL,et al.Impact of urbanization on morbidity of hepatitis A:A national panel study in China during 2005-2018[J].Infect Dis Poverty,2023,12(1):56-56.
[13] Sun XJ,Zhang GM,Zhou RJ,et al.Changes in the epidemiology of hepatitis A in three socio-economic regions of China,1990-2017[J].Infect Dis Poverty,2019,8(5):22-29.
[14] 张淼. 2002—2019年中国大陆地区甲型病毒性肝炎发病趋势和空间关联性[J].河南预防医学杂志,2021,32(5):325-330.
[15] Yang Q,Lin T,Zhao Y,et al.International disease burden of acute viral hepatitis among adolescents and young adults:An observational study[J].J Viral Hepat,2024,31(2):96-106.
[16] Rao A,Wanjari MB,Prasad R,et al.From mystery to clarity:Uncovering the possible cause of hepatitis outbreak in children[J].Cureus,2023,15(5):e38388.
[17] Wang F,Sun X,Wang F,et al.Changing epidemiology of hepatitis A in China:Evidence from three national serological surveys and the National Notifiable Disease Reporting System[J].Hepatology,2020,73(4):1251-1260.
[18] 江晓宁,李明星.10~20岁人群甲肝疫苗接种效果初探[J].疾病预防控制通报,2021,36(1):51-52.
[19] 罗小福,金明娟,张超.湖州市扩大免疫规划前后甲型病毒性肝炎流行特征分析[J].预防医学,2018,30(11):1120-1123.
[20] 缪宁,王富珍,郑徽,等.2020年中国3—14岁儿童甲型肝炎疫苗接种率调查[J].中国疫苗和免疫,2022,28(5):581-585.

基于Joinpoint回归模型分析2005—2021我国甲型肝炎发病趋势

Incidence trend of hepatitis A in China from 2005 to 2021：an analysis based on Joinpoint regression model

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

Metrics

本文评价

推荐阅读 0

[1]	尚萌琳, 谢今朝, 王旭, 刘聪, 钟海丹, 杜佩珊, 李全敏, 蔡卫平, 李凌华, 顾菁. 2010—2021年广州市初治HIV感染者糖脂代谢异常患病趋势及其年龄-时期-队列模型分析[J]. 华南预防医学, 2024, 50(3): 246-250.
[2]	孙鹏摇, 孙雪竹, 许婷婷, 陈开训, 吕东来. 296例肝癌病例肝炎病毒基因型分布[J]. 华南预防医学, 2021, 47(7): 898-901.